Screener
Charles River Laboratories CRL Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| 3.75% Senior Notes due 2029 | 500,000 | 500,000 |
| 4.00% Senior Notes due 2031 | 500,000 | 500,000 |
| Other debt | 7,240 | 7,842 |
| Finance leases | 9,848 | 27,876 |
| Total debt and finance leases | 2,637,381 | 2,152,221 |
| Less: | ||
| Current portion of long-term debt | 5,460 | 166 |
| Current portion of finance leases | 1,166 | 3,228 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's finance lease liabilities?
- Charles River Laboratories (CRL) reported finance lease liabilities of $9.85M in Q2 2026.
- How has Charles River Laboratories's finance lease liabilities changed year-over-year?
- Charles River Laboratories's finance lease liabilities decreased by 65.5% year-over-year, from $28.55M to $9.85M.
- What is the long-term trend for Charles River Laboratories's finance lease liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's finance lease liabilities has grown at a -1.1% compound annual growth rate (CAGR), from $26.03M to $24.65M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Charles River Laboratories's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude